Envista Holdings (NVST) Liabilities and Shareholders Equity (2017 - 2026)
Envista Holdings (NVST) recorded quarterly Liabilities and Shareholders Equity of $5.6 billion in Q2 2026, down 1.78% quarter-over-quarter from $5.7 billion in Q4 2025, and up 2.04% on a YoY basis from $5.5 billion in Q2 2025.
Envista Holdings (NVST) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
Envista Holdings' Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $5.6 billion for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 2.04% year-over-year to $5.6 billion; the TTM figure through Apr 2026 stood at $22.6 billion (up 3.67% YoY), while the FY2025 annual figure was $5.7 billion, up 6.14% from the prior year.
- Liabilities and Shareholders Equity was $5.6 billion for Q2 2026 at Envista Holdings, down from $5.7 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $6.7 billion in Q3 2023 to a low of $5.4 billion in Q4 2024.
- Historically, Liabilities and Shareholders Equity has averaged $6.1 billion across 5 years, with a median of $6.4 billion in 2022.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity decreased 18.99% in 2024, then increased 6.14% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $6.6 billion in 2022, then advanced by 0.27% to $6.6 billion in 2023, then slipped by 18.99% to $5.4 billion in 2024, then gained by 6.14% to $5.7 billion in 2025, then decreased by 1.78% to $5.6 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $5.6 billion (Q2 2026), $5.7 billion (Q4 2025), and $5.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | 5.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 5.58 Bn |
| Dec 31, 2025 | 5.68 Bn |
| Sep 26, 2025 | 5.64 Bn |
| Jun 27, 2025 | 5.66 Bn |
| Mar 28, 2025 | 5.47 Bn |
| Dec 31, 2024 | 5.35 Bn |
| Sep 27, 2024 | 5.51 Bn |
| Jun 28, 2024 | 5.44 Bn |
| Mar 29, 2024 | 6.56 Bn |
| Dec 31, 2023 | 6.61 Bn |
| Sep 29, 2023 | 6.68 Bn |
| Jun 30, 2023 | 6.61 Bn |
| Mar 31, 2023 | 6.58 Bn |
| Dec 31, 2022 | 6.59 Bn |
| Sep 30, 2022 | 6.41 Bn |
| Jul 1, 2022 | 6.46 Bn |
| Apr 1, 2022 | 6.57 Bn |
| Dec 31, 2021 | 6.57 Bn |
| Oct 1, 2021 | 6.56 Bn |
| Jul 2, 2021 | 6.48 Bn |